BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of 86.00 million. The enterprise value is 74.87 million.
| Market Cap | 86.00M |
| Enterprise Value | 74.87M |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | Nov 29, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.05% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.76M |
Valuation Ratios
The trailing PE ratio is 16.35.
| PE Ratio | 16.35 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.49, with an EV/FCF ratio of 15.19.
| EV / Earnings | 14.23 |
| EV / Sales | 3.12 |
| EV / EBITDA | 12.49 |
| EV / EBIT | 12.99 |
| EV / FCF | 15.19 |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.92 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.16 |
| Interest Coverage | 134.43 |
Financial Efficiency
Return on equity (ROE) is 19.77% and return on invested capital (ROIC) is 13.94%.
| Return on Equity (ROE) | 19.77% |
| Return on Assets (ROA) | 11.91% |
| Return on Capital (ROIC) | 13.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.42% in the last 52 weeks. The beta is 0.93, so BioSyent's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +21.42% |
| 50-Day Moving Average | 8.00 |
| 200-Day Moving Average | 7.41 |
| Relative Strength Index (RSI) | 47.24 |
| Average Volume (20 Days) | 3,195 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of 25.54 million and earned 5.26 million in profits. Earnings per share was 0.44.
| Revenue | 25.54M |
| Gross Profit | 20.29M |
| Operating Income | 6.13M |
| Pretax Income | 6.95M |
| Net Income | 5.26M |
| EBITDA | 6.27M |
| EBIT | 6.13M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
The company has 12.63 million in cash and 802,677 in debt, giving a net cash position of 11.83 million.
| Cash & Cash Equivalents | 12.63M |
| Total Debt | 802,677 |
| Net Cash | 11.83M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.64M |
| Book Value Per Share | 2.38 |
| Working Capital | 15.19M |
Cash Flow
In the last 12 months, operating cash flow was 4.97 million and capital expenditures -47,005, giving a free cash flow of 4.93 million.
| Operating Cash Flow | 4.97M |
| Capital Expenditures | -47,005 |
| Free Cash Flow | 4.93M |
| FCF Per Share | n/a |
Margins
Gross margin is 79.42%, with operating and profit margins of 23.99% and 20.60%.
| Gross Margin | 79.42% |
| Operating Margin | 23.99% |
| Pretax Margin | 27.20% |
| Profit Margin | 20.60% |
| EBITDA Margin | 24.55% |
| EBIT Margin | 23.99% |
| FCF Margin | 19.29% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.67%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 1.67% |
| Dividend Growth (YoY) | 10.15% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 28.69% |
| Buyback Yield | 3.05% |
| Shareholder Yield | 4.71% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 10.67.
| Altman Z-Score | 10.67 |
| Piotroski F-Score | n/a |